Receive Your Dual CRISPRi & CRISPRa Screening Poster

Whole genome CRISPR screens to understand how your drug works

View the first direct combination of all three approaches (CRISPRko, CRISPRi and CRISPRa) in the context of genome-wide screens to identify components that influence resistance and sensitivity to the standard of care BRAF inhibitor, vemurafenib.

Learn the benefits of:

Re-purposed CRISPR tools for drug target identification and validation
Identification of pathway modulators that affect both drug sensitivity and resistance
Combining the loss and gain-of-function screening to reveal complex gene networks which control drug response

Simply fill in the form to receive your poster!

* Indicates a required field

Business Email*

First Name*

Last Name*

Job Function*

Company/Institute*

Business Phone*

City

Country*

State or Province*

Zip or Postal Code

I have read & understand the Horizon Privacy statement and agree to the processing of my data.

Hereby I give my consent to receive emails from Horizon Discovery